Highlights Doximity, Inc.

Equities

DOCS

US26622P1075

Real-time Estimate Cboe BZX Other stock markets 15:19:34 2024-05-10 EDT			5-day change	1st Jan Change
23.36 ^USD	-1.70%		-3.01%	-16.67%

04-26	North American Morning Briefing : Tech Still in -2-	DJ
04-25	JPMorgan Upgrades Doximity to Neutral Rating From Underweight, Price Target is $25	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

North American Morning Briefing : Tech Still in -2-	04-26	DJ
Doximity Business Under Pressure as Underlying Sales Falling, Jehoshaphat Research Says	04-01	MT
Tranche Update on Doximity, Inc.'s Equity Buyback Plan announced on June 6, 2023.	02-08	CI
Doximity, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-08	CI
Doximity Fiscal Q3 Non-GAAP EPS, Revenue Increase; Q4 Outlook Set; Shares Fall After Hours	02-08	MT
Doximity Guides For Q4 Revenue of $115.9-$116.9 Million, vs CIQ Analyst Consensus of $118 Million	02-08	MT
Earnings Flash (DOCS) DOXIMITY Reports Q3 Revenue $135.3M, vs. Street Est of $127.5M	02-08	MT
Earnings Flash (DOCS) DOXIMITY Posts Q3 EPS $0.29, vs. Street Est of $0.24	02-08	MT
Doximity, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year Ending March 31, 2024	02-08	CI
Tranche Update on Doximity, Inc.'s Equity Buyback Plan announced on November 9, 2023.	02-07	CI
Doximity Fiscal Q2 Non-GAAP EPS, Revenue Rise; FY Revenue Forecast Boosted; Buyback Set; Shares Jump After Hours	11-09	MT
Tranche Update on Doximity, Inc.'s Equity Buyback Plan announced on November 10, 2022.	11-09	CI
Tranche Update on Doximity, Inc.'s Equity Buyback Plan announced on June 6, 2023.	11-09	CI
Doximity, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-09	CI
Doximity Guides For Q3 Revenue of $127-$128 Million, vs CIQ Analyst Consensus of $123 Million; FY 2024 Revenue Seen at $460-$472 Million, vs Consensus of $461 Million	11-09	MT
Doximity, Inc. Provides Revenue Guidance for the Fiscal Third Quarter Ending December 31, 2023 and Fiscal Year Ending March 31, 2024	11-09	CI
Doximity, Inc. announces an Equity Buyback for $70 million worth of its shares.	11-09	CI
Earnings Flash (DOCS) DOXIMITY Posts Q2 EPS $0.22, vs. Street Est of $0.18	11-09	MT
Earnings Flash (DOCS) DOXIMITY Reports Q2 Revenue $113.6M, vs. Street Est of $109.1M	11-09	MT
Doximity Launches Docdefender, Expanding Services to Safeguard Physician Privacy	11-01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Doximity, Inc.

Equities

DOCS

US26622P1075

Highlights

Filters